PMID: 11604357Oct 18, 2001Paper

Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?

Bulletin du cancer
A Fléchon, J P Droz

Abstract

Germ-cell tumor patients are cured in 80% of cases. Twenty per cent of patients had a relapse or an incomplete response after first line chemotherapy, and only one third of them are alive free of disease at long term. Different approaches were performed to increase the results either in first line chemotherapy of poor prognosis patients or in first salvage. High dose chemotherapy with stem-cell support is one of them. The drugs infused are etoposide, carboplatin, cyclophosphamide and ifosfamide. Actually, no randomized performed trial showed the superiority of high dose chemotherapy in first line or in salvage treatment. Randomized trials are on going in these two settings. High dose chemotherapy is not actually a standard treatment in germ cell tumors.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.